
    
      A diagnostic prospective single-site study, with no anticipated risks or constraints.

      Primary objective- To validate the value of a set of breath VOC biomarkers that enable us to
      distinguish between Coronavirus (SARS-CoV-2) carriers and SARS-CoV-2-negative in comparison
      to the gold-standard testing methodology.
    
  